Congratulations to University of Kentucky students who placed 2nd in the Emory Global Health Institute's 4th Annual International Global Health Case Competition. UK students competed among an elite group of 24 teams in the competition held in Atlanta, GA in March. Teams were given one week to develop strategies for reducing gun violence in Honduras and presented their proposals to a panel judges at the Rollins School of Public Health.
The Christ Hospital Health Network (TCHHN) in Cincinnati, Oh., announced today an affiliation with the University of Kentucky Markey Cancer Center, the state's first and only National Cancer Institute-designated cancer center. The affiliation will provide patients with more cancer treatment options and advanced education and research.
“We look forward to expanding healthcare choices for patients with cancer with this affiliation,” said Mike Keating, president and CEO of The Christ Hospital Health Network.
What if a failed leukemia drug could reduce the risk of Alzheimer’s disease? A team at the University of Kentucky recently led an effort to investigate this hypothesis. Their results were published today in the journal, Human Molecular Genetics.
The UK researchers, led by Steve Estus at the Sanders-Brown Center on Aging, study a genetic variant in a gene called CD33 that reduces the risk of Alzheimer’s disease. The Estus group recently published findings suggesting that this variant promotes production of a truncated form of the CD33 protein that lacks a putative functional domain.
Next week, KET will feature three University of Kentucky experts discussing cancer care in a set of programs that will accompany the three-part documentary series Cancer: The Emperor of All Maladies by Ken Burns.
The series, which will air March 30, 31 and April 1 at 9 p.m., is based on the Pulitzer Prize-winning book The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee.
On Sunday, March 29, at 1 p.m. on KET, UK Markey Cancer Center Director Dr.
Dr. John H. Eichhorn, professor of Anesthesiology and Provost’s Distinguished Service Professor at the University of Kentucky College of Medicine, authored a paper earlier in his career titled, "Standards for Patient Monitoring During Anesthesia at Harvard Medical School," which is named in the current issue of the prestigious journal, Anesthesia and Analgesia, as one of the top 20 most important articles in anesthesiology ever written.
The Anesthesia and Analgesia review of the most important articles cites papers dating back to 1846 when the use of ether was first demonstrated (No.
Before fourth-year University of Kentucky medical students Kenisha Webb and Tom Muse opened acceptance letters to their medical residency programs, they calculated their odds of landing at the same location.
UK HealthCare has established the Office for Value and Innovation in Healthcare Delivery (OVIHD), aiming to provide value-based care across our health system. By re-engineering care delivery using expertise from industry, UK HealthCare will undergo a transformation of its delivery system to optimize care coordination for patients.
“As the health care delivery system continues to evolve, we must be ready to respond to market needs, without losing focus on patient safety and care across the health care continuum,” said Dr. Michael Karpf, UK executive vice president for health affairs.
UK Health Care pediatrician Dr. Lindsay B. Ragsdale was recently elected as chair of the Pediatric Special Interest Group for the American Academy of Hospice and Palliative Care Medicine (AAHPM).
Ragsdale is the associate director of the Pediatric Advanced Care Team (PACT), which serves families of seriously ill children at Kentucky Children's Hospital (KCH). PACT focuses on improving quality of life, communicating health information to families and managing pain for patients in many sections of the hospital.
Xiang-An Li, Ph.D., of the University of Kentucky Saha Cardiovascular Research Center and Department of Pediatrics, has been awarded a $3 million grant from the National Institutes of Health to study synthetic HDL (sHDL) as a potential therapy for sepsis.
Sepsis -- also called septicemia -- is a life-threatening condition caused by an overwhelming immune response to infection. Immune chemicals released by the body into the bloodstream to fight the infection trigger widespread inflammation that can damage multiple organ systems.
Governor Steve Beshear, joined by legislative leaders, today signed legislation authorizing construction of a multidisciplinary research building at the University of Kentucky.
House Bill 298 provides for a state-of-the-art facility which will house world-class research across health disciplines. Research will focus on the many health challenges facing the Commonwealth, particularly those which contribute to preventable diseases and deaths.
“This project represents the potential to improve the lives of so many, both within Kentucky where our health outcomes are so poor, and beyond,” Gov.
Join us on this memorable day and share in the excitement for our graduates. The Graduation Ceremony will be held on Saturday, May 16 at 1:30 p.m. in the Concert Hall of the Singletary Center for the Arts located at 405 Rose Street. This event is free and open to the public. There will be a reception following the ceremony.
LEXINGTON, Ky. (March 9, 2015) — A trip to the school library in Paris, France set the foundation for a love story that spans nearly 30 years and two continents.
Elodie Elayi, and her husband, Samy-Claude Elayi were born, raised and educated in France.
To date, a cure for Parkinson's disease remains elusive for the more than 50,000 Americans diagnosed yearly, despite decades of intensive study. But a newly approved treatment that might help ease the symptoms of Parkinson's has shown remarkable promise.
Parkinson’s is a progressive disease caused by the death of dopamine-producing cells in the brain.
Nathan Vanderford, assistant director for research at the University of Kentucky Markey Cancer Center and assistant professor in the Department of Toxicology and Cancer Biology, has a featured article on graduate education in the March 5 edition of Nature. Nature is one of the most prominent and prestigious interdisciplinary scientific journals in the world.
Vanderford co-wrote an article titled, "Wanted: Information" with Viviane Callier from the Ronin Institute for Independent Scholarship.
University of Kentucky President Eli Capilouto believes it is time "to make death a beggar in Kentucky.”
It’s the idea that through world-class research across an array of disciplines, and a commitment to working as partners with communities across the state, some of the most stubborn health challenges and statistics that plague Kentucky can be successfully attacked.
On Tuesday, the state General Assembly and Gov.
University of Kentucky women's basketball coach Matthew Mitchell will headline the University of Kentucky Sanders-Brown Center on Aging Foundation Dinner celebrating great minds on April 23. The event, presented and sponsored by Alltech, will be held at the Lexington Center in downtown Lexington, with more than 700 people expected to attend.
Each year, the dinner hosts a guest speaker who is either an example of successful aging or who has a personal connection to Alzheimer’s and age-related diseases. Previous guest speakers have included such well-known figures as Captain Chesley B.
The UK American Medical Association (AMA) Chapter was recently named the winner of the Healthy Body, Healthy Mind Community Service Competition hosted by Region 5 of the AMA Medical Student Section (MSS). Healthy Body, Healthy Mind was a region-wide community service campaign that targeted elementary school children living in urban and rural areas at highest risk of developing obesity and dropping out of school.
The National Cancer Institute recently awarded a two-year, $357,743 grant to University of Kentucky Markey Cancer Center researchers to study the role of a certain protein in aggressive cancer metastasis.
The lab of Kathleen O'Connor, professor in UK's Department of Molecular and Cellular Biochemistry, studies how tumor cells interact with their environment to make cancer more aggressive.
Specifically, O'Connor's lab studies a protein called integrin α6β4, a protein that integrates signals from its environment so that cells can respond properly and die off if they are in the wrong context.
The Gill Heart Institute at the University of Kentucky is participating in a multi-center clinical trial of a new medical device that has the potential to improve the outcomes and reduce the incidence of angina for patients with coronary artery disease (CAD).
For decades, cardiologists opened blocked coronary arteries using balloons and followed that by implanting stents (mesh-like devices) that act like scaffolds to maintain the patency of the artery. Traditionally, stents are a permanent implant made of metal.
